News & Press

  • Nov 7, 2016

    Clinical Study Shows AstaReal® Astaxanthin Effective in Reducing both Mental and Physical Fatigue

    TOKYO, JAPAN – November 4, 2016 – A new clinical study published in the Journal of Clinical Therapeutics & Medicines has demonstrated that AstaReal® astaxanthin was simultaneously effective against both mental and physical fatigue. The study was conducted by AstaReal Co., Ltd, and it is believed to be the first time that a single active ingredient has been demonstrated to possess both of these properties.As everyday fatigue is a mixture of mental and physical fatigue, the dual anti-fatigue benefits of astaxanthin are expected to be highly valued in the supplement market. Read the Press Release The same press release will be distributed on the same day from the subsidiaries of AstaReal Group; AstaReal AB (Sweden), AstaReal Pte. Ltd. (Singapore)

  • Sep 9, 2016

    AstaMed® MYO, Prescription Medical Food for Clinical Dietary Management of Sarcopenia, Meets Primary One Month Objective of Increased Muscle Strength in Two Phase Study

    The New Formulation From Astavita Containing Proprietary Natural Astaxanthin Significantly Improved Muscle Strength in a Randomized, Double-Blind, Placebo-Controlled Clinical Study at the University of Washington BELLEVUE, WA--(Sep 8, 2016) - Astavita, Inc., a WA-based provider of nutraceutical products containing proprietary natural astaxanthin and a global brand of AstaReal Group, today announced the interim results of a clinical study showing patients with sarcopenia significantly improved muscle strength as a result of receiving 30 days of a natural astaxanthin formulation without any lifestyle modifications or additional exercise protocols. The ongoing study is designed to explore the effectiveness of AstaMed MYO among sarcopenia adult patients who have impaired muscle function. Final results are anticipated in Q4' 2016 or Q1' 2017. The official launch of AstaMed MYO is scheduled for Q4' 2016 and will be available from pharmacies. During this interim period, patients demonstrated statistically significant double digit improvements in muscle strength (maximal voluntary…

  • Aug 12, 2016

    The First Moses Lake Health Challenge Closed with 55 Finishers!

    AstaReal held a closing celebration of the first Moses Lake Health Challenge on July 30th. In the ceremony, we announced overall results and individuals with significant improvement with the benefit of AstaReal® astaxanthin. Moses Lake Health Challenge is a health initiative program for research and education targeting at population with lifestyle-related risks in the U.S. local communities. It was conducted from February 29th to June 11th, 2016 in Moses Lake, WA. 55 participants with BMI over 25 who had out-of-range blood and physiological parameters were enrolled 3 month open label study. During this period, they engaged in regular exercise and took Astavita® Healthy Living Antioxidant dietary supplement (12mg of astaxanthin and 20mg of tocotrienol per day); manufactured in Moses Lake from AstaReal group. As a result, important markers such as lipid metabolism and liver condition were improved. (See attached PDF for more detail.) Columbia Basin Herald, the local newspaper for Moses Lake,…

  • Jun 24, 2016

    AstaReal, Inc. Responds to Misleading BGG North America Announcement – There are No “FDA‐Allowed Structure / Function Claims;” Calls for the Industry to be Cautious

    BURLINGTON, NJ – AstaReal, Inc., which sells astaxanthin under the brand name AstaReal, has issued a caution to retail manufacturers of their legal obligations to evaluate their astaxanthin label claims based on the facts and their own substantiation reviews. The caution has been issued in response to a news release disseminated in mid-May by BGG North America Inc. and/or its affiliated entity, Algae Life Sciences, Inc. (collectively, “BGG”) asserting its astaxanthin ingredient AstaZine has attained the “landmark achievement” of procuring “239 FDA-Allowed Structure/Function Claims” through the mere act of sending the agency a notification. In fact, there are already more than 100 such notifications on file with the FDA for a variety of structure/function claims submitted by dozens of companies marketing astaxanthin-containing products to retail consumers. Joe Kuncewitch, National Sales Manager of AstaReal, Inc., explained, “It is our understanding that the FDA does not 'allow' the use of structure/function claims…

  • Jun 18, 2016

    The AstaReal Group Announces Dr. Robert Corish as Global Scientific Ambassador & Medical Advisor

    The AstaReal Group has appointed Dr. Robert Corish as Global Ambassador & Medical Advisor to further strengthen their commitment to educate the world about natural astaxanthin´s outstanding benefits for human health and unlimited potential within preventative health care. Dr. Corish obtained a Medical Doctorate (M.D) at the University of Miami, Florida. He is Board Certified in Anesthesiology & Pain Management, trained in Clinical Toxicology, and is recognized as an expert in Preventative Medicine with extensive expertise in natural astaxanthin.  “I am delighted to become a member of the AstaReal Group. The AstaReal® brand is the Industry’s Gold Standard in natural astaxanthin and I look forward to contributing to the Group´s further success,” said Dr. Corish. “AstaReal® is the most clinically studied brand of natural astaxanthin and the AstaReal Group is recognized as the authority in human clinical studies. As a medical doctor, it is imperative to be supported by the science, as…